GlassScriptPhysician profile
Gary Leo Bernardini
NPI 1417957713
$898.11
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $23.74 · 2021: $149 · 2022: $168.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $312.01 | 2019 | |
| Pfizer INC. | $117.79 | 2019 | |
| Sk Life Science, INC. | $104.46 | 2021-2022 | |
| Chiesi USA, INC. | $88.62 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $67.82 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $58.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $38.41 | 2019-2021 | |
| Ucb, INC. | $34.60 | 2021 | |
| Medtronic USA, INC. | $29.45 | 2019 | |
| Neurelis, INC. | $23.74 | 2020 | |
| Biogen, INC. | $22.26 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bernardini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.